Table 1.
Variables | Description | Number of patients | GEF-H1 expression
|
χ2 | P-value | |
---|---|---|---|---|---|---|
Low | High | |||||
Primary tumor ulceration | With | 38 | 14 | 24 | 3.695 | 0.055 |
Without | 22 | 3 | 19 | |||
Lymph node metastases | 0 | 57 | 16 | 41 | 3.322 | 0.190 |
1 | 1 | 1 | 0 | |||
2–3 | 2 | 0 | 2 | |||
Distant metastases | No distant metastases | 57 | 17 | 40 | 1.248 | 0.264 |
Distant skin, subcutaneous or nodal metastases | 3 | 0 | 3 | |||
Tumor thickness | ≤4 mm | 27 | 11 | 16 | 3.722 | 0.054 |
>4 mm | 33 | 6 | 27 | |||
TNM stage | I | 5 | 2 | 3 | 13.931 | 0.003** |
II | 22 | 12 | 10 | |||
III | 30 | 3 | 27 | |||
IV | 3 | 0 | 3 |
Notes:
GEF-H1 has correlation with TNM stage.
Abbreviation: GEF-H1, guanine nucleotide exchange factor H1.